Stockscreener 앱 받기
17.08
1.84%
-0.32
시장 영업 전:
17.01
-0.07
-0.41%
전일 마감가:
$17.40
열려 있는:
$17.15
하루 거래량:
13.79M
Relative Volume:
1.42
시가총액:
$8.79B
수익:
$11.24B
순이익/손실:
$-900.00M
주가수익비율:
-10.17
EPS:
-1.679
순현금흐름:
$323.00M
1주 성능:
-4.63%
1개월 성능:
-13.69%
6개월 성능:
-28.45%
1년 성능:
-50.62%
1일 변동 폭
$16.84
$17.71
1주일 범위
$16.84
$18.55
52주 변동 폭
$16.84
$35.03
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.08 | 8.79B | 11.24B | -900.00M | 323.00M | -1.679 |
|
ISRG
Intuitive Surgical Inc
|
483.46 | 171.69B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.27 | 45.59B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.79 | 37.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.75 | 33.89B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.61 | 33.59B | 5.40B | 1.49B | 1.78B | 10.12 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
BofA Maintains Neutral on Baxter International Inc. (BAX) March 2026 - Meyka
Baxter International (NYSE:BAX) Sets New 12-Month LowHere's What Happened - MarketBeat
Baxter Announces CFO Transition: Joel Grade Departs, Anita Zielinski Named Interim CFO, Reaffirms 2026 Outlook - Minichart
Baxter International stock hits 52-week low at $16.99 By Investing.com - Investing.com Canada
Baxter International stock hits 52-week low at $16.99 - Investing.com
Baxter says CFO Joel Grade is leaving the company - Crain's Chicago Business
Baxter International CFO Joel Grade to depart for family reasons - Medical Economics
Baxter International (BAX) Announces CFO Transition - GuruFocus
Baxter (BAX) CFO Transition as Joel Grade Steps Down - GuruFocus
BofA reiterates Baxter stock rating at Neutral on CFO transition - Investing.com
Baxter International (BAX) Announces CFO Transition and Interim Appointment - GuruFocus
Baxter International Inc. Announces the Departure of Joel Grade as Executive Vice President, Effective from April 30, 2026 - marketscreener.com
Baxter International Appoints Interim CFO Amid Leadership Transition - TipRanks
Baxter CFO Joel Grade to leave, Zielinski named interim - Investing.com
Baxter Announces CFO Transition - The Joplin Globe
How Investors Are Reacting To Baxter International (BAX) Governance Probes And Novum LVP Safety Allegations - simplywall.st
Assessing Baxter International (BAX) Valuation After Downgrades And Novum LVP Legal Scrutiny - Yahoo Finance
The Bull Case For Baxter International (BAX) Could Change Following New Governance And Safety Probes – Learn Why - Yahoo Finance
Is Baxter International (BAX) Now Attractive After Steep Multi Year Share Price Declines? - simplywall.st
Barclays Reaffirms Their Buy Rating on Baxter International (BAX) - The Globe and Mail
Dodge & Cox Has $1.31 Billion Position in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Baxter International Inc. (NYSE: BAX) Long Term Investor Alert: Investigation of potential Wrongdoing - openPR.com
Baxter’s new CEO paid $29.8 million in first five months on the job - Crain's Chicago Business
Despite Near-Term Headwinds, Baxter Aims for a Turnaround Under New Management - Morningstar
Form PRE 14A BAXTER INTERNATIONAL For: May 05 - StreetInsider
Quantitative Investment Management LLC Makes New $2 Million Investment in Baxter International Inc. $BAX - MarketBeat
Intravenous (IV) Solutions Market Size to Reach USD 29.47 Billion by 2035 Due to the Increasing Prevalence of Chronic Diseases Globally | SNS Insider - GlobeNewswire Inc.
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Citi Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $19 - 富途牛牛
Why Baxter International Inc. stock remains undervaluedJuly 2025 Reactions & Community Driven Trade Alerts - mfd.ru
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Citigroup Lowers Price Target for Baxter International (BAX) Ami - GuruFocus
Baxter at Barclays Conference: Strategic Shifts Amid Challenges - Investing.com
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Citigroup - MarketBeat
Russell Investments Group Ltd. Has $57.24 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter (NYSE: BAX) SVP forfeits shares to cover tax withholding - Stock Titan
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Sets New 52-Week LowWhat's Next? - MarketBeat
Baxter International stock hits 52-week low at $17.26 - Investing.com India
Blood Tubing Set Market Is Going to Boom Rapidly | Baxter International • Terumo Corporation • Fresenius Kabi - openPR.com
Baxter International Inc. $BAX Stake Increased by Gamco Investors INC. ET AL - MarketBeat
Gabelli Funds LLC Has $15.87 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Is Baxter International Inc. stock a contrarian buyPortfolio Profit Report & Daily Chart Pattern Signals - Naître et grandir
Is Baxter International (BAX) Pricing In Too Much Bad News After Its Sharp Share Price Fall - simplywall.st
Baxter Reshapes Portfolio With Kidney Spin Off And Margin Focus - Yahoo Finance
How Baxter International Inc. stock valuations compare to rivalsOil Prices & Weekly Setup with ROI Potential - Naître et grandir
Will Baxter International Inc. stock recover faster than peersTrade Volume Summary & Real-Time Volume Triggers - Naître et grandir
Why Baxter International Inc. stock could be next big winnerExit Point & AI Forecasted Entry and Exit Points - Naître et grandir
Baxter International Inc (BAX) Shares Gap Down to $17.875 on Mar 6 - GuruFocus
Sticking With Baxter At The Lows (NYSE:BAX) - Seeking Alpha
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
0.10%
자본화:
|
볼륨(24시간):